Nykredit A/S’s Prestige Consumer Healthcare PBH Stock Holding History

Nykredit A/S’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$133K	Buy	+2,808	New	+$144K	﹤0.01%	1199

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nykredit A/S's PBH Position: Q2 2026 in Review

Nykredit A/S opened a new position in Prestige Consumer Healthcare (PBH) in Q2 2026: 2,808 shares worth $133K. The stake represents ﹤0.01% of the portfolio and ranks #1199 among its holdings.

244 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

Nykredit A/S held 2,808 shares of Prestige Consumer Healthcare worth $133K as of Q2 2026.
Prestige Consumer Healthcare was a new Nykredit A/S position in Q2 2026.
Prestige Consumer Healthcare made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1199 holding.
244 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.